PharmaVOICE - 
March 2007
Purchase Issue

In Every Issue
PharmaOutlet
Overcoming Challenges to the Path to Combination Product Development Combination [...]
By

Christine Ford

For Art’s Sake
A Creative Review by the Experts Each month, this department [...]
By
Talent Pool
Pharma POOL Dr. Lou Barbato Tikvah Names VP, Clinical R&D, [...]
By
E-Media
Thomson Scientific Expands Pharmaceutical Regulatory Intelligence Coverage Thomson Scientific announces [...]
By
What’s New
CommonHealth Celebrates Opening Of Paris Office The move is designed [...]
By
On the Calendar
March 15-16 Prescription Drug Pricing InterContinental The Barclay, New York [...]
By
Letter from the Editor
Leadership development is a concern for all executive management teams, [...]
By

Taren Grom, Editor

UpFront
Movers & Shakers HBA Honorees Woman of the Year, Honorable [...]
By
Raise Your Voice — Letters
Site Value I think most agree the PI/coordinator/patient relationship is [...]
By
PharmaTrax
Drug Counterfeiting Creates Need for RFID in European Markets The [...]
By

On The Cover

Leadership Development: The Next Generation
By Taren Grom Life-sciences organizations operate in a complex and challenging environment that includes tighter funding, reimbursement restrictions, longer and more expensive product development cycles, and more regulatory oversight. Whether future leaders are prepared to manage in this complex and evolving environment, according to experts at Spencer Stuart, depends a great deal on the organizations’ [...]
By

Taren Grom, Editor

Features

EDC: Crossing the Chasm
In the figurative but practical language of Silicon Valley marketing guru Geoffrey Moore, the leading EDC companies have “crossed the chasm” from the fluidity of the early adopter market to the more established needs of the mainstream market. This may be the dream of many an EDC company CEO, but it is not an easy [...]
By
Moving Science Forward — Dr. Russell M. Medford
By Kim Ribbink With a pioneering spirit that has led him to tackle emerging fields of science, Russell M. Medford, M.D., Ph.D., is striving to ensure that AtheroGenics, the company he cofounded in 1993, is creating breakthrough medications for chronic inflammation. March 2007 Entrepreneurial spirit is about taking risks and forging new paths, which is [...]
By

Kim Ribbink

Managed Markets: Medicare
Although Medicare’s Part D prescription drug program has been a success in many ways, legislators are considering tinkering with the program. By Denise Myshko More of America’s seniors have access to prescription drugs than they did two years ago — and at less cost than first predicted. Still, many experts say Medicare’s prescription drug plan, [...]
By

Denise Myshko

CME: Measuring the Impact
By Denise Myshko Outcomes assessment of continuing education can help determine whether there is a change in participants’ knowledge and performance. March 2007 Barbara Winkelman CME LLC Over time, there is going to be a change in how CME is delivered and how outcomes are measured; there will be more collaboration between CME providers. The [...]
By

Denise Myshko

A New Era in the Science of Aging
By Cynthia Borda Older Americans face new and growing challenges in managing chronic diseases, which are now the leading causes of death among people older than the age of 65. Every seven seconds someone in the United States is celebrating a 60th birthday. This trend began Jan. 1, 2006, and will continue for 18 years. [...]
By

Cynthia Borda

Master Plan: The Making of a Successful Publication Strategy
By Elisabeth Pena Villarroel Publication planning is an essential part of the drug-development process. The results of the long, labor-intensive years of a clinical trial are announced to the industry and medical professionals through publication in medical journals. Preparing trial results for publication requires early planning to ensure that important scientific data are communicated to [...]
By

Elisabeth Pena Villarroel

Global Connections
By Taren Grom, Editor Global outsourcing, as it relates to international sponsor/supplier relationships, is constantly changing and growing. Pharmaceutical companies and their partners can gain significant competitive advantages through global outsourcing when sound business practices are applied to the management and care of these relationships. Sally Goostrey The W Group Since every country has different [...]
By

Taren Grom, Editor

FEEDBACK